UFMylation-dependent inhibition of AKT signaling by PHLDA3 in lung adenocarcinoma
Cell Reports · 2026-04 · 45 (4) · 117154
DOI: 10.1016/j.celrep.2026.117154 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cell Reports, 2026-04. Verfasst von Xiuqing Ma und 10 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Bioactive Molecules and Druggability Assessment, Guangdong Basic Research Center of Excellence for Natural Bioactive Molecule…. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: China Postdoctoral Science Foundation, Basic and Applied Basic Research Foundation of Guangdong Province, Science and Technology Program of Gansu Province.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- State Key Laboratory of Bioactive Molecules and Druggability Assessment, Guangdong Basic Research Center of Excellence for Natural Bioactive Molecules and Discovery of Innovative Drugs, College of Pharmacy/International…
- School of Pharmacy and State Key Laboratory of Natural Product Chemistry, Lanzhou University, Lanzhou 730000, China.
- Department of Pathology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China. Electronic address: son…
- School of Pharmacy and State Key Laboratory of Natural Product Chemistry, Lanzhou University, Lanzhou 730000, China. Electronic address: wangshh@lzu.edu.cn.
Förderung
- China Postdoctoral Science Foundation
- Basic and Applied Basic Research Foundation of Guangdong Province
- Science and Technology Program of Gansu Province
- National Key Research and Development Program of China
- Guangzhou Municipal Science and Technology Project
- National Natural Science Foundation of China
Zitieren
APA
Ma, X., Wan, R., Yang, X., Tang, J., Wen, Y., Huang, L., Li, X., Song, Y., Zhou, Y., Wang, S. H., & Liu, T. (2026). UFMylation-dependent inhibition of AKT signaling by PHLDA3 in lung adenocarcinoma. Cell Reports, 45(4), 117154. https://doi.org/10.1016/j.celrep.2026.117154
Vancouver
Ma X, Wan R, Yang X, Tang J, Wen Y, Huang L, et al. UFMylation-dependent inhibition of AKT signaling by PHLDA3 in lung adenocarcinoma. Cell Reports. 2026;45(4):117154. doi:10.1016/j.celrep.2026.117154
BibTeX
@article{Ma2026,
author = {Ma, Xiuqing and Wan, Rui and Yang, Xiao and Tang, Jiaxin and Wen, Yalei and Huang, Lei and Li, Xinying and Song, Yan and Zhou, Yang and Wang, Shao-Hua and Liu, Tongzheng},
title = {UFMylation-dependent inhibition of AKT signaling by PHLDA3 in lung adenocarcinoma},
journal = {Cell Reports},
year = {2026},
volume = {45},
number = {4},
pages = {117154},
doi = {10.1016/j.celrep.2026.117154}
}
EUVIMED